Lawsuit settlements drag Sun Pharma into ₹2,227 cr loss in Q4
Sun Pharma incurred an exceptional loss of ₹3,936 crore on account of settlements, provisions related to Taro Pharmaceuticals, Ranbaxy.
sun pharma q4
May 2022
